PCSK9 promotes aging-related cardiac calcification by inducing osteogenic differentiation of cardiac fibroblasts
Mechanisms of Ageing and Development · 2026
DOI: 10.1016/j.mad.2026.112215 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mechanisms of Ageing and Development, 2026. Verfasst von Gang Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Henan Key Laboratory of Medical Tissue Regeneration, Henan Medical University, Xinxiang, China. Hauptthemen laut MEDLINE: Osteogenesis, Cell Differentiation, Proprotein Convertase 9, Aging. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Xinxiang Medical University.
Abstract (Originalsprache)
Cardiac calcification is an age-associated pathological process that contributes to cardiac dysfunction, arrhythmia, and sudden cardiac death, yet its underlying mechanisms remain unclear. Cardiac fibroblasts (CFs) have emerged as key mediators of ectopic calcification through osteogenic differentiation. Proprotein convertase subtilisin/kexin type 9 (PCSK9), a key regulator of cholesterol metabolism, has been implicated in cardiovascular pathology beyond its canonical role, but its involvement in cardiac calcification is unknown. In this study, aged mice exhibited cardiac dysfunction, interstitial fibrosis, and myocardial calcium deposition, accompanied by upregulation of osteogenic markers, including Runx2, OCN, and Osx. PCSK9 expression was increased in aged hearts and enriched in DDR2-positive cells. In vitro, senescent CFs displayed enhanced osteogenic differentiation, characterized by increased calcium deposition, alkaline phosphatase activity, and elevated expression of osteogenic markers. Recombinant PCSK9 promoted osteogenic differentiation in young CFs, whereas genetic deletion of PCSK9 attenuated these effects in senescent CFs. Pharmacological experiments suggest that PCSK9-mediated osteogenic differentiation is associated with activation of the ATF4 pathway and upregulation of Runx2 expression. These findings support a role for the PCSK9-ATF4-Runx2 signaling axis in osteogenic differentiation of CFs, providing new insights into age‑related cardiac calcification and identifying this pathway as a hypothesis‑generating candidate for future investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Henan Key Laboratory of Medical Tissue Regeneration, Henan Medical University, Xinxiang, China.
- Institute of Psychiatry and Neuroscience, Xinxiang Key Laboratory of Protein Palmitoylation and Major Human Diseases, Henan Medical University, Xinxiang, China.
- Henan Key Laboratory of Medical Tissue Regeneration, Henan Medical University, Xinxiang, China. Electronic address: 161042@xxmu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Xinxiang Medical University
Zitieren
APA
Liu, G., Cai, Q., Ye, L., Pan, B., Ye, C., Zhang, S., Sun, Y., Cui, C., Lu, C., & Wang, X. (2026). PCSK9 promotes aging-related cardiac calcification by inducing osteogenic differentiation of cardiac fibroblasts. Mechanisms of Ageing and Development. https://doi.org/10.1016/j.mad.2026.112215
Vancouver
Liu G, Cai Q, Ye L, Pan B, Ye C, Zhang S, et al. PCSK9 promotes aging-related cardiac calcification by inducing osteogenic differentiation of cardiac fibroblasts. Mechanisms of Ageing and Development. 2026. doi:10.1016/j.mad.2026.112215
BibTeX
@article{Liu2026,
author = {Liu, Gang and Cai, Qiuya and Ye, Lin and Pan, Binbin and Ye, Chenji and Zhang, Shuhong and Sun, Yongkun and Cui, Chaochu and Lu, Chengbiao and Wang, Xianwei},
title = {PCSK9 promotes aging-related cardiac calcification by inducing osteogenic differentiation of cardiac fibroblasts},
journal = {Mechanisms of Ageing and Development},
year = {2026},
doi = {10.1016/j.mad.2026.112215}
}
EUVIMED